The IABP, developed in the 1960s, was the first device to provide temporary mechanical support to the heart in patients with cardiogenic shock, Sacco said. Although other such devices have been ...

Understanding Intra-Aortic Balloon Pump Technology The IABP was first used in humans in the 1960s. It was the first type of ...

Similar to deleterious consequences of early balloon inflation Early deflation Reduced inflation time, leading to lower peak diastolic augmentation and suboptimal IABP function. Theoretically ...

PARIS — Early implantation of an intra-aortic balloon pump (IABP) in patients with decompensated heart failure (HF) and low output provided more effective treatment than inotropic agents in a ...

Leveraging the patented technology of the AC3 Optimus™ IABP, the AC3 Range™ IABP is designed to provide reliable, ongoing IABP support across various patient transport modes, including ...

Intra-aortic balloon pump did not outperform standard therapy in cardiogenic shock, with similar survival rates and adverse events. Tirzepatide reduced cardiovascular events and improved symptoms ...

“There were no prior large-scale contemporary studies evaluating Impella-assisted high-risk PCI compared to IABP support in real-world clinical practice,” Alexandra J. Lansky, MD (Yale School of ...

A percutaneous left ventricular assist device fails to offer improvement in 30-day outcomes compared with intra-aortic balloon pump (IABP) therapy in high-risk patients requiring hemodynamic support ...

The intra-aortic balloon pump (IABP), while effective in adults, could be limited in effectiveness in infants because of differences in coronary dynamics, central vascular impedence, heart rate ...

Get Instant Summarized Text (Gist) Early use of an intra-aortic balloon pump (IABP) in patients with cardiogenic shock due to heart failure did not improve 60-day survival or facilitate transition ...